Chia Siang Kow, MPharm
- 2Articles
- 7.4KReads1
- 2020–2021Active
- 1Collaborators
About
Chia Siang Kow, MPharm, is affiliated with the School of Postgraduate Studies at the International Medical University in Kuala Lumpur, Malaysia. Kow has published on topics including addiction, COVID-19, and psychopharmacology, focusing on drug-drug interactions involving interleukin-6 inhibitors and pharmacologic treatments for opioid use disorder, as well as the use of medications with weight gain potential in panic disorder during the COVID-19 pandemic. Kow's work has appeared in Psychiatrist.com, contributing between 2020 and 2021. Frequent collaboration with Syed Shahzad Hasan is noted.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
